AI-generated summary
The authors report a prospective, randomized, split-face study of 30 women with melasma, comparing fractional picosecond 1,064 nm laser plus 4% hydroquinone cream against hydroquinone cream alone on the other side of the face. The mMASI score at 12 weeks was significantly lower on laser-treated areas, while melanin index, satisfaction and quality of life showed no differences.
- Participants
- 30
- Who or what was studied
- Female subjects with melasma
- Limits stated in the abstract
- The abstract reports a single small split-face study with only 30 completers and no differences on several secondary outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 064 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.